Skip to content
POM-V Prescription Required Companion Animal

Baytril Flavour Tablets 50 mg

Active ingredient: Enrofloxacin

Form

Tablet

Species

Dogs

Manufacturer

Elanco GmbH

VMD MA No.

52127/3064

What it's used for

Pigs: For the treatment of bacterial bronchopneumonia caused by enrofloxacin-susceptible Actinobacillus pleuropneumoniae, Pasteurella multocida and complic...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Enrofloxacin

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Baytril Flavour Tablets 50 mg — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Pigs:
For the treatment of bacterial bronchopneumonia caused by enrofloxacin-susceptible
Actinobacillus pleuropneumoniae, Pasteurella multocida and complicated by
Haemophilus parasuis as secondary pathogen in pigs.
with Baytril 5% Injection or Baytril 2.5% Injection and maintained with Baytril Flavour
Tablets.
The daily dose is achieved as follows:
Medium dogs: 1 Baytril Flavour Tablet 50 mg per 10 kg bodyweight
Not for use in dogs less than 1 year of age or in exceptionally large breeds of
dog with a longer growth period under 18 months of age, as articular cartilage
may be affected during the period of rapid growth.
The veterinary medicinal product should not be used for prophylaxis.
Dogs
Mild and transient.
As a result of gastrointestinal disorders.
During the period of rapid growth articular cartilage development may be affected.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or the national competent authority via
the national reporting system. See the package leaflet for respective contact details.
Please refer to item 3.3.

Special precautions for safe use in the target species:
Do not exceed the recommended dosage.
Fluoroquinolones should be reserved for the treatment of clinical conditions which
have responded poorly, or are expected to respond poorly, to other classes of
antimicrobials.
Whenever possible, fluoroquinolones should only be used based on susceptibility
testing.
Use of the veterinary medicinal product deviating from instructions given in the SPC
may increase the prevalence of bacteria resistant to fluoroquinolones and may
decrease the effectiveness of treatment with other quinolones due to the potential for
cross resistance.
Official and local antimicrobial policies should be taken into account when the
veterinary medicinal product is used. In cases of pyoderma, possible underlying
primary disease should be identified and treated.
Enrofloxacin is partially excreted via the kidneys; as with all fluoroquinolones,
excretion may therefore be delayed in individuals with existing renal damage.
The veterinary medicinal product should be used with caution in animals with severe
renal or hepatic impairment. Retinotoxic effects including blindness can occur in cats
when the recommended dose is exceeded.
Enrofloxacin-containing products should not be used in animals with persisting
articular cartilage growth disorders, since disorders may worsen during treatment.
Do not use in cases of known resistance to quinolones or fluoroquinolones
because of near-total cross-resistance to the former and complete cross-
resistance to the latter.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
-
Enrofloxacin may cause hypersensitivity (allergic reactions). People with
known hypersensitivity to enrofloxacin or to any of the excipients should avoid
contact with the veterinary medicinal product.
-
The veterinary medicinal product may be irritant to skin and eyes. In case of
contact with skin or eyes, wash the affected area with clear running water.
-
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
Other precautions:
None
Do not use enrofloxacin concomitantly with antimicrobial substances acting
antagonistically to quinolones (e.g. macrolides, tetracyclines, or phenicols).
Do not use concurrently with theophylline as the elimination of theophylline may be
delayed.
Very rare
(< 1 animal / 10,000 animals
treated, including isolated
reports):
Digestive tract disorders
(e.g. diarrhoea,
hypersalivation, vomiting);
Anorexia
;
Anaphylactic-type reaction;
Neurological disorders (e.g. ataxia, seizure,
tremor, excitation);
Joint cartilage disorder
.
Care should be taken during the concomitant use of flunixin and enrofloxacin in
dogs to avoid adverse drug reactions. The decrease in drug clearances as a result
of coadministration of flunixin and enrofloxacin indicates that these substances
interact during the elimination phase. Thus, in dogs, the co-administration of
enrofloxacin and flunixin increased the AUC and the elimination half-life of flunixin
and increased the elimination half-life and reduced the Cmax of enrofloxacin.
Concurrent oral applications of substances containing calcium, aluminium or
magnesium hydroxide (e.g. antacids), or multivitamins containing iron or zinc can
interfere with intestinal absorption of fluoroquinolones. Enrofloxacin should therefore
not be used concomitantly with those products.
The combined use of fluoroquinolones with digoxin should also be avoided because
of potentially increased oral bioavailability of digoxin.
Do not store above 25°C. Store in a dry place.
Not applicable.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.